      Document 0015
 DOCN  DRG0015
 UNIQUE IDENTIFIER        DRG-0232
 NAME OF SUBSTANCE        P3C541b Lipopeptide [FDA 090]
 PROTOCOL ID NUMBERS      FDA 090
 SECONDARY SOURCE ID      DRG
 DISEASES STUDIED/TREATED Primary HIV infection. [FDA 090]
 CLASSIFICATION CODE      Vaccine [FDA 090]
 CHEMICAL/PHYSICAL DATA   DRUG DESCRIPTION: Lipopeptide [FDA 090]
 SUBSTANCE DELIVERY DATA  MODE OF DELIVERY: Subcutaneous. [FDA 090]
 MANUFACTURERS            United Biomedical Inc
 ENTRY MONTH              9510
 LAST REVISION DATE       951102
 

SOURCE: National Library of Medicine, Bethesda, MD.  Distributed by AEGIS.
